Skip to main content

Table 1 Clinical characteristics of patients from which ascites were obtained and characteristic features of cells isolated

From: Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma

Ascites Sample No.

Age

Histopathology

Origin

Stage

Prior CT

Clinical intervention

Cell Morphology

Percentage of cells with

CK-18 (+)/Vimentin (+)

1

85

OSA

ascites

IIIC

yes

Neoadjuvant CT

Mesenchymal-like

6.5%/95.3%

2

54

OSA

ascites

IIIC

yes

Recurrence

Epithelial-like

73.1%/11.2%

3

45

OSA

ascites

IIIC

yes

Recurrence

Epithelial-like

79.8%/8.5%

4

62

OSA

ascites

IIIC

No

Primary surgery

Mesenchymal-like

25.1%/85.5%

       

Epithelial-like

79.5%/9.2%

5

62

OSA

ascites

IC

No

Primary surgery

Mesenchymal-like

21.3%/90.4%

6

57

OSA

ascites, tissue

IIC

No

Primary surgery

Mesenchymal-like

15.3%/92.7%

        

4.8%/92.3%

7

46

OSA

ascites

IIIC

Yes

Recurrence

Mesenchymal-like

21.4%/87.2%

8

48

OSA

ascites

IIIC

No

Primary surgery

Mesenchymal-like

15.9%/91.5%

   

tissue

    

4.7%/97.5%

9

53

OSA

ascites

IIIC

No

Primary surgery

Mesenchymal-like

24.3%/91.7%

   

tissue

    

3.5%/98.1%

10

48

OSA

ascites

IIIC

No

Primary surgery

Mesenchymal-like

13.9%/94.5%

   

tissue

    

5.5%/94.8%

11

28

OMBT

ascites

IA

No

Primary surgery

Mesenchymal-like

4.7%/98.9%

12(3)

45

OSA

ascites

IIIC

yes

Recurrence

Mesenchymal-like

5.4%/93.5%

13(7)

46

OSA

ascites

IIIC

Yes

Recurrence

Mesenchymal-like

1.3%/99.4%

14(11)

28

OMBT

ascites

IA

Yes

Recurrence

Mesenchymal-like

4.2%/98.7%

15

37

OCCA

ascites

IC

Yes

Recurrence

Mesenchymal-like

1.4%/97.1%

16

52

OCCA

ascites

IC

Yes

Secondary debulking

Mesenchymal-like

6.2%/91.8%

17

71

OCCA

ascites, tissue

IIIC

No

Primary surgery

Mesenchymal-like

8.2%/93.1%

        

3.2%/95.7%

18

61

OSA

tissue

IIIC

no

primary surgery

Mesenchymal-like

4.3%/96.1%

19

73

OSA

tissue

IIIC

no

primary surgery

Mesenchymal-like

7.1%/92.5%

20

N/A

Endometriosis

ascites

N/A

N/A

N/A

Mesenchymal-like

3.2%/97.8%

       

Epithelial-like

99.1%/3.4%

  1. ( ): Sample obtained from the same patient No.
  2. OSA: ovarian serous adenocarcinoma; OCCA: ovarian clear cell adenocarcinoma; OMBT: ovarian mucinous borderline tumor
  3. CT: chemotherapy
  4. N/A: not applicable